Company intelligence / Profile preview

Damon’s International

Needham Heights, Massachusetts, USA

Ownership: Private
Development stage: Other

Overview

Damon Biotech was a pioneering biotechnology company founded in the early 1980s as a subsidiary of Damon Corporation. The company was best known for its proprietary Encapcel microencapsulation technology, which was utilized for the large-scale production of monoclonal antibodies and the delivery of biological drugs. Its primary therapeutic focus included the development of pro-urokinase for the treatment of blood clots and various monoclonal antibody-based diagnostics and therapies. Damon Biotech was a significant player in the first wave of biotechnology firms before being acquired by Abbott Laboratories in 1989.

Therapeutic areas: OncologyCardiovascular
Modalities: Monoclonal antibodyProteinRecombinant protein
Industry: Biotech

Partnerships

SmithKline BeckmanYamanouchi Pharmaceutical

Beyond the preview

Go deeper on Damon’s International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Damon’s International.

Explore the full profile